Sheldon Lidofsky, MD
Gastroenterology · Providence, RINPI 1447336904
Payments from drug & device makers
Across 422 payments — averaging $1427.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$371K
- E.r. Squibb & Sons, L.L.C.$223K
- AbbVie$5K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$850
- Johnson & Johnson$791
- Takeda Pharmaceuticals U.S.A., Inc.$523
- plus $2K from 17 others
Across 3 payments — averaging $796.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 10 | $370,697 |
| E.r. Squibb & Sons, L.L.C. | 10 | $222,765 |
| AbbVie | 207 | $4,500 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 39 | $850 |
| Johnson & Johnson(2 entities) | 33 | $791 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $523 |
| Pfizer | 27 | $486 |
| Bristol Myers Squibb | 15 | $391 |
| Gilead | 13 | $248 |
| Lilly USA, LLC | 11 | $245 |
| Intercept Pharmaceuticals, Inc. | 6 | $149 |
| Ironwood Pharmaceuticals, Inc | 6 | $119 |
| Merck | 7 | $117 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Braintree Laboratories, Inc. | 1 | $72 |
| Ardelyx, Inc. | 3 | $58 |
| QOL Medical, LLC | 1 | $41 |
| Ferring Pharmaceuticals Inc. | 3 | $40 |
| Fresenius Kabi USA, LLC | 1 | $26 |
| Sanofi | 1 | $26 |
| Romark Laboratories, LC | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Olympus America Inc. | 1 | $13 |
How this compares
$602,274 in reported general payments places this provider in the 95th percentile of 85 gastroenterology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Providence
- Lisa MuellerProvidence$750K
- Thomas SepeProvidence$739K
- Jason FerreiraProvidence$355K
- Eric NewtonProvidence$353K
- Paul AkermanProvidence$123K
- Alan EpsteinProvidence$61K
- Sean FineProvidence$55K
- Breton RousselProvidence$50K
- Samir ShahProvidence$28K
- Nabil ToubiaProvidence$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.